Vitamins
Minerals
Fitness Nutrition
Omega & Fish Oil
Nutritional Drinks
Sexual Wellness
Liver Care
Immunity Boosters
Digestive Care
Diabetic Care
Bone & Joints Care
Respiratory Care
Women Care
Skin Care
Ear Nose Throat
Skin Care
Oral Care
Hair Care
Men Grooming
Baby Food
Baby Hair Care
Baby Skin Care
Baby Bath Care
Diapers
Feminine Hygiene
Women Grooming
Women Nutrition
Blood Glucose
Blood Pressure
Support & Braces
Health Vitals
Test Kits
Nebulizers
Oral Contraceptives
Condoms
Pleasure Enhancers
Protective Gear
Personal & Home
Prescription Required.Why?
Is the active ingredient in the medication.
Imeglimin is currently in clinical trials and is not yet approved for any specific medical conditions. Therefore, it is not available for prescription or purchase.
It is being investigated as a potential treatment for type 2 diabetes.
0 Imezemic 1000 Tab (Imeglimin) is believed to work by enhancing insulin sensitivity and glucose uptake in the body, which helps regulate blood sugar levels.1 It is being studied for its potential to improve glucose metabolism and reduce insulin resistance.2 The exact mechanism of action is still under investigation.
As Imeglimin is not currently available on the market, specific storage and handling information is not applicable.
If you have any questions regarding medication storage, always consult with your healthcare provider or pharmacist.
Because Imeglimin is not commercially available, dosage and administration information is not applicable.
Since Imeglimin is still in clinical trials, the full range of potential side effects is not yet known.
As Imeglimin is not yet approved for use, specific advice regarding alcohol consumption is not available. Consult your doctor if you have any concerns.
Imeglimin has not been assessed for its potential effects on driving or operating machinery. Consult with your doctor or pharmacist if you have any concerns.
Because Imeglimin is not available for prescription, information about its safety during pregnancy and breastfeeding is not applicable.
Imeglimin is not currently studied for use in children, and its safety for this population is not known.
The potential effects of Imeglimin on kidney function are not fully understood. Clinical trials are ongoing to assess safety and efficacy in various patient groups.
The potential effects of Imeglimin on liver function are not fully understood. Clinical trials are ongoing to assess safety and efficacy in various patient groups.
Clinical trial information about Imeglimin may be found on clinical trial registries such as ClinicalTrials.gov.
